Contents

SynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyDrug Reaction DataReferences

Information for Patients

View all Images (10)

Oral candidiasis in Infant/Neonate
See also in: Oral Mucosal Lesion
Other Resources UpToDate PubMed

Oral candidiasis in Infant/Neonate

See also in: Oral Mucosal Lesion
Contributors: Vivian Wong MD, PhD, Kiasha Govender MBChB, MMed, FCDerm, Anisa Mosam MBChB, MMed, FCDerm, PhD, Ncoza C. Dlova MBChB, FCDerm, PhD, Susan Burgin MD
Other Resources UpToDate PubMed

Synopsis

Oral candidiasis, also called oropharyngeal candidiasis and commonly known as oral thrush, is a common cause of infection of the oral mucous membranes by Candida species, especially Candida albicans. It is common during infancy when the immune system and immune responses are developing.

Transmission of infection occurs either at the time of delivery during passage through the vaginal canal or after delivery during handling or breastfeeding. Neonates who become infected at the time of delivery usually present with symptoms between ages 2 and 4 weeks. Infection later on in infancy can result from repeated use of antibiotics or occur in infants with HIV infection or a primary immunodeficiency syndrome.

Oral candidiasis appears in a number of clinical forms. The most common form is the pseudomembranous variety: white plaque formation typically appears on the tongue, lips, inner surface of the cheeks, and palate and can leave behind punctate bleeding and patches of reddened mucosa when scraped.

Candida at the corners of the mouth is known as angular cheilitis or perlèche. Crusting, small ulcers, or fissures can be present at the angles of the mouth.

The infant may be symptomless or may be generally irritable and show a decreased willingness to feed.

Immunocompromised patient considerations: Oral candidiasis is seen with greater frequency in patients with leukemia or other malignancies, individuals with AIDS, and individuals receiving immunosuppressive agents (eg, systemic corticosteroids, azathioprine, cyclosporine A, or tacrolimus). Patients with diabetes are also predisposed. Risk factors for oral candidiasis in the HIV-infected population include low CD4 count (< 200 cells/microl) and being antiretroviral naïve. Laryngeal and/or esophageal involvement may occur in concert with oral candidiasis in immunocompromised patients. Isolated laryngeal involvement has been reported from inhaled corticosteroids.

Related topics: angular cheilitis, congenital candidiasis, diaper dermatitis candidiasis, neonatal candidiasis

Codes

ICD10CM:
B37.0 – Candidal stomatitis

SNOMEDCT:
79740000 – Candidiasis of mouth

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

To perform a comparison, select diagnoses from the classic differential

Subscription Required

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

Drug Reaction Data

Subscription Required

References

Subscription Required

Last Reviewed:09/23/2024
Last Updated:10/13/2024
Copyright © 2024 VisualDx®. All rights reserved.
Patient Information for Oral candidiasis in Infant/Neonate
Print E-Mail Images (10)
Contributors: Medical staff writer
Premium Feature
VisualDx Patient Handouts
Available in the Elite package
  • Improve treatment compliance
  • Reduce after-hours questions
  • Increase patient engagement and satisfaction
  • Written in clear, easy-to-understand language. No confusing jargon.
  • Available in English and Spanish
  • Print out or email directly to your patient
Copyright © 2024 VisualDx®. All rights reserved.
Oral candidiasis in Infant/Neonate
See also in: Oral Mucosal Lesion
A medical illustration showing key findings of Oral candidiasis (Adult/Child) : Dysphagia, Oral burning sensation, Altered taste
Clinical image of Oral candidiasis - imageId=176995. Click to open in gallery.  caption: 'Small, flat, white papules on the dorsal tongue.'
Small, flat, white papules on the dorsal tongue.
Copyright © 2024 VisualDx®. All rights reserved.